Form D · Biotechnology
Scipher Medicine Corp
Waltham, MA · CIK 0001658821
Offering snapshot reported Jul 30, 2024 · SEC filing
- Reported sold
- $5.85M Offering amount: $5.85M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 2, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 30, 2024 | Initial | $5,849,013 | No comparison | 1 | SEC filing |
| Mar 31, 2021 | Amendment | $81,999,988 | $0vs Mar 26, 2021 | 12 | SEC filing |
| Mar 26, 2021 | Initial | $81,999,988 | No comparison | 12 | SEC filing |
| Oct 10, 2019 | Amendment | $24,999,873 | $4,999,985vs May 20, 2019 | 15 | SEC filing |
| May 20, 2019 | Initial | $19,999,888 | No comparison | 14 | SEC filing |
| Aug 17, 2018 | Initial | $8,533,437 | No comparison | 11 | SEC filing |
| May 24, 2018 | Initial | $795,000 | No comparison | 5 | SEC filing |
| Nov 7, 2016 | Initial | $575,000 | No comparison | 12 | SEC filing |
| Nov 30, 2015 | Initial | $225,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-520134
Source: Form D, filed Jul 30, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tim Anderson | Director |
| Albert Laszlo Barabasi | Director |
| Albert Laszlo Barabsi | Director |
| Ingo Chakravarty | Director |
| Byron Kalogerou | Executive |
| Samir Kaul | Director |
| Miklos Kobor | Director |
| Albert Laszlo Barabasi | Director |
| Joseph Loscalzo | Director |
| Glenn Muir | Director |
| Michael Rubin | Director |
| Peter Ruppert | Director |
| Jeffrey Sachs | Executive |
| Alif Saleh | Director, Executive |
| Reginald Seeto | Director, Executive |
| Todd Sone | Director |
| Marcell Veidner | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
500 Totten Pond Road, 6 Th Floor
Waltham, MA, 02451
Waltham, MA, 02451